Buying opportunity in Stride pharmaOn weekly charts, this scripts seems on strong support zone near 280 indicating the ascending RSI above 30 levels.
On financial sides, though the YoY revenue generation is seen weak, the Q4 revenue is up by more than 6.50%.
Short term holding can deliver targets 320, 342, 360
